Ape1 is a molecule with dual functions in DNA repair and redox regulation of transcription factors. In Ape1 deficient mice, embryos do not survive beyond embryonic day 9, indicating that this molecule is required for normal embryo development. Currently, direct evidence of the role of Ape1 in regulating hematopoiesis is lacking. We used the ES cell differentiation system and a siRNA approach to knock down Ape1 gene expression to test the role of Ape1 in hematopoiesis. Hemangioblast development from ES cells was reduced 2 to 3 fold when Ape1 gene expression was knocked down by Ape1 specific siRNA, as was primitive and definitive hematopoiesis.
Introduction
Ape1/Ref-1 is a multifunctional protein involved in apurinic/apyrimidinic endonuclease DNA base excision repair activity, in proofreading exonuclease activity, and in modulating DNA binding activity of several transcription factors including NFkB, Egr-1, p53, AP-1, CREB, HIF-α and members of the Pax family 1 . Ape1 acts on apurinic/apyrimidinic (AP) sites in DNA as a major member of the base excision repair (BER) pathway and is involved in oxidative DNA damage repair 2 . Ape1 is ubiquitously expressed at high basal levels and in previous studies to determine the function of Ape1 in vivo, Ape1 was disrupted using a gene targeting strategy 3 . Embryos lacking expression of Ape1 die in utero between implantation and day 6.5, indicating that Ape1 is required for normal embryonic development. However, this approach does not allow for the determination of whether it is the redox or repair function of Ape1 that is crucial for embryonic development. Furthermore, this early lethality precludes analysis of the role of Ape1 in hematopoiesis.
Mouse embryonic stem (ES) cells are derived from the inner cell mass of the 3.5-dayold blastocyst 4, 5 . ES cells retain the differentiation ability of the inner cell mass after many passages in the presence of leukemia inhibitory factor (LIF) 6 . Removal of LIF results in ES cell differentiation into embryoid bodies (EB) 7 . Using the ES/EB system, a precursor that responds to vascular endothelial growth factor (VEGF) and generates colonies consisting of undifferentiated blast cells was identified 8 . These VEGFresponsive blast cell colonies were shown to contain endothelial, primitive erythroid, and various definitive hematopoietic precursors. These cells are referred to as blast colony-forming cells (BL-CFC) and are thought to be cells that represent the hemangioblast precursor of blood and endothelial lineages.
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Ape1 siRNA has previously been used to knock down target gene expression in several cell types [9] [10] [11] . In this study, we used siRNA to knock down Ape1 gene expression in EB cells and discovered that reduction of Ape1 by siRNA results in a significant decrease in the frequency of hemangioblast formation and diminished formation of primitive and definitive hematopoietic colonies. Additionally, using an Ape1 specific redox inhibitor, E3330, we demonstrate that it is the redox function of Ape1 and not the repair activity that is involved in hematopoietic differentiation. These data suggest that Ape1 may play a critical role in embryonic hematopoiesis 5 at a cell concentration of 5 ~10x10 3 cells / ml plated in a 100 mm low adhesion dishes.
Materials and method

Cells and reagents
Harvesting EBs
EBs were removed from liquid medium IMDM. 
Transfection of EB cells with oligos of dsRNA
Transient transfection of siRNAs was carried out as we previously reported 7, 13 . Total EB cells were diluted with fresh medium without antibiotics and transferred to 12-well plates at 1 x 10 5 cells/well (500 µl per well). Transient transfection of dsRNAs was carried out using Oligofectamine 2000 (Life Technologies, Carlsbad, CA, USA). Cells were untreated (control), or treated with scrambled Ape1 siRNA (25~50nM), or Ape1 siRNA (25~50nM).
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Clonogenic cell assay
For hemangioblast assay, after siRNA transfection, day-3 EB cells were mixed with IMDM, 20% FCS, 10% BSA (Stem Cell Technology), 100 µg/ml bovine transferrin, 10ng/ml bovine insulin, 0.1 mmol/L MTG, 1% methylcellulose, and distributed to 35-mm bacterial-grade dishes at 10 4 cells/plate with VEGF, SCF, DT4 conditional medium (CM). For primitive erythroid cell (Ery-P) assay, day 6 EB cells were cultivated with EPO at 5 IU/ml as previously described 14 . For granulocyte-macrophage (CFU-GM) colony assay, day 10 EB cells were cultured with granulocyte-macrophage colonystimulating factor (GM-CSF) at 10 ng/ml and macrophage colony-stimulating factor (M-CSF) at 5 ng/ml 14 .
RT-PCR
Total RNA was extracted from undifferentiated ES cells and EB cell populations by using TRIZOL (Invitrogen. USA), Reverse transcription was performed using Superscript II reverse transcriptase (GIBCO BRL, Carlsbad, CA, USA), and PCR was performed using Pyrobest DNA polymerase. Primer sequences for Brachyury, Flk-1, and scl genes have been reported 8 . The primer sequence of β-actin gene has been reported 15 .
Western blot analysis
Whole cell extracts were prepared using nuclear protein extract buffer (Laribee and Klemsz, 2001) from both Ape1-siRNA or scrambled siRNA treated and untreated cells.
The cell lysates were separated by SDS-polyacrylamide electrophoresis using a 10%
(w/v) polyacrylamide resolving gel and transferred electrophoretically to a nitrocellulose membrane. The blots were blocked with 5% TBS/T buffer for 1 hr.
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Immunobloting was performed using the Ape1 primary monoclonal antibody (Novus Biologicals, Littleton, CO, USA) at a 1:400 dilution at room temperature, and the peroxidase-conjugated secondary Abs (Amersham Pharmacia, USA) over night at 4 ºC.
This antibody has been extensively used by us and others 11, [16] [17] [18] [19] [20] All immunoblots were visualized by enhanced chemiluminescence (ECL) (Amersham Pharmacia Biotech, USA).
Inhibition of DNA repair domain of Ape1 with MX and redox domain with E3330.
E3330 is a specific inhibitor of redox activity of Ape1 protein, while MX is a specific inhibitor of the DNA repair (AP endonuclease) function of Ape1 protein. MX does not specifically bind to Ape1, but binds to the abasic site that is recognized by Ape1 and prevents Ape1's ability to cleave the AP site [21] [22] [23] [24] [25] .
E3330 has been shown to be a very specific inhibitor of Ape1 redox function. Farwestern blots, and binding assays between radiolabeled E3330 and proteins renatured on membrane blots, demonstrated that 14 C-labeled E3330 specifically bound to both recombinant APE1 and purified APE1 from cell nuclear extracts 26 . The binding constant of APE1 and E3330 was estimated by surface plasmon resonance analysis (SPR) resulting in a kinetic constant value of 1.6 nM which suggests a specific interaction between APE1 and E3330 26 . Therefore, E3330 is a specific inhibitor of APE1 redox function. E3330 does not affect the repair function of Ape1 (Kelley and Luo, unpublished data).
To verify the role of Ape1 in hemangioblast development via redox domain or DNA repair domain, various doses of E3330 (10 -100 µM) or MX (1-10mM) were added to 9 standard hemangioblast culture. Hemangioblast colonies were scored after 4 days of culture.
Cell cycle analysis
EB cells were treated with either scrambled siRNA or Ape1 siRNA. After 48 hours of culture, cells were washed with PBS, and resuspended in 400 µL of hypotonic buffer (0.15% Triton-X100 and 20 µg/ml of RNase A) containing 50 µg/ml of Propidium Iodide ( PI), and analyzed using FACScan (BD Bioscience, Mountain view, CA).
Results
Ape1 is expressed in both undifferentiated and differentiated ES cells
To examine whether Ape1 is expressed in ES cells and differentiated ES cells, we isolated total cell protein from ES cells, and day 3, 6, or 10 EB cells. Western blot analysis showed that Ape1 protein is detectable in both ES cells and EB cells (Fig.1A) .
Further experiments showed that Ape1 siRNA, but not scrambled control siRNA, is effective to knockdown Ape1 gene expression in EB cells when probed by western blot analysis after 48 h of siRNA transfection (Fig.1B) .
Normal hemangioblast development from ES cell development
ES cells differentiate to EBs in the absence of LIF in culture. Day 3 EB cells replated into culture wells with VEGF and SCF results in the emergence of hemangioblast colonies. Some residual undifferentiated ES cells in EB were able to differentiate into a cell mass called secondary EBs, that are round bodies with a smooth edge and are easy to distinguish from hemangioblast colonies ( Fig. 2A) . We separately collected BLCFCs or 2 nd EBs and RT-PCR analysis revealed that they differ in their gene expression pattern (Fig. 2B) . Knockdown of Ape1 gene expression results in a decrease of BL-CFC formation and an increase in the 2 nd EB numbers in the culture (Fig. 2C,D) .
Ape1 is essential for both primitive and definitive hematopoiesis
To test the role of Ape1 in primitive erythroid progenitor (Ery-P) cell development, day 6 EBs were dissociated and EB cells were replated in methylcellulose culture medium supplemented with plasma derived serum and with erythropoietin. Knockdown of Ape1 expression in day 6 EB cells blunted their potential to form Ery-P ( Figure 3A) . To determine whether a reduction of Ape1 expression affected definitive hematopoiesis,
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Ape1 siRNA was introduced into dissociated day 10 EB cells followed by progenitor (Fig. 4A , B, C).
Knockdown of Ape1 gene expression in EB cells did not induce apoptosis in these cells
To determine whether or not knockdown of Ape1 gene expression in EB cells induced apoptosis, siRNA transfected cells were harvested after 48 hours of transfection and stained with Annexin V and PI. The cells were then analyzed by FACS. As shown in Figure 5 , knockdown of Ape1 gene expression with siRNA did not trigger apoptosis in EB cells. In contrast, cells treated with IFN-γ displayed robust apoptosis (Fig. 5) .
Inhibition of Ape1 redox activity by E3330 but not DNA repair activity by
methoxyamine affects hemangioblast development in vitro
To address which functional domain in the Ape1 molecule may play the major role in regulation of hematopoiesis, we added the Ape1 redox inhibitor E3330 (0 -100 µM) or the Ape1 abasic site excision inhibitor, MX (0 ~ 10mM) to add to the cultured EB cells. Inhibition of Ape1 redox activity by E3330, but not Ape1 DNA repair activity by MX affected cytokine-mediated hemangioblast development in vitro (Fig.6) .
Furthermore, the inhibition of BL-CFC and Ery-P colony formation via E3330 was dose dependent.
Knock down of Ape1 in EB cells induces G1 arrest in EB cells
To examine whether or not the decrease in frequency of hematopoietic colonies was caused by low cell proliferation, we performed cell cycle analysis of the cells treated In previous studies, PDGF-BB stimulated cell cycle progression from G0/G1 to S in smooth muscle cells, with one of the postulated steps being redox-regulation of AP-1 by Ape1 protein 32 . Therefore, we wanted to see if Ape1 may play a role in growth factor stimulated cell cycle regulation. We report here that Ape1 regulates cell cycle status in hematopoietic progenitors and that Ape1 also positively regulate G1/S transition in EB cells. The cell cycle arrest of Ape1 siRNA treated EB cells may be one mechanism to explain diminished hematopoietic CFC activity reported here. Future studies will need 15 to prove how Ape1 may regulate cyclin dependent kinases and cyclins that are critical for G/S transition.
In conclusion, this study presents direct evidence that Ape1 positively regulates embryonic hematopoiesis through its redox function. However, the target of Ape1's redox signaling has not been identified by this type of analysis and additional studies will need to address which downstream target or targets are involved in this pathway.
As this study was limited to investigation of the regulatory role of Ape1 in embryonic hematopoiesis using the ES cell system, further studies to identify a possible role for
Ape1 in adult myelolymphoid development may prove insightful. 
Figure Legends
